|Bid||188.79 x 200|
|Ask||188.82 x 500|
|Day's Range||188.18 - 189.32|
|52 Week Range||167.88 - 199.91|
|PE Ratio (TTM)||N/A|
|Expense Ratio (net)||0.09%|
The ADP March jobs report was published on April 4, 2018. It offered a deeper insight into employment trends across different sectors in the US employment market. ADP and Moody’s analytics prepare this monthly report.
ADP, a human capital management solutions provider, releases a monthly report on US non-farm employment. Changes to the level of hiring and gains in employment across different sectors in the United States are captured in the report. ADP processes the payrolls of more than 24 million workers in the United States, which gives the organization a unique insight into the US employment market.
It is often said that large-caps, many of which are multi-national firms generating significant portions of their revenue overseas, benefit from a weak dollar while smaller companies, due to their domestic ...
Globus Medical (GMED) is a medical device company with a focus on designing, developing, and commercializing musculoskeletal solutions. Globus Medical’s sales force is comprised of direct sales representatives and distributor sales representatives employed by exclusive independent distributors. Of the 13 analysts covering Globus Medical in February 2018, seven of them have given the stock a “buy” or higher rating.
It may be surprising to hear that in a year in which ETFs are shattering all sorts of records with regard to the amount of money they are taking in, the world's largest exchange-traded fund isn't participating in the bonanza. That's right; the SPDR S&P 500 ETF Trust (SPY), the $242 billion behemoth, has actually had net outflows this year to the tune of $4.2 billion.
In April 2017, United Therapeutics (UTHR) and 3D Systems (DDD) declared their plans to develop solid organ scaffolds for human transplants.
Any negative news from the jobs report will be foreshadowed by the tax reform news. It's the last jobs report before the September FOMC meeting.
In 1Q17, Bioverativ reported revenues close to $259.0 million, driven by its focus on a commercial strategy for its hemophilia products and optimal cost management.
Abiomed is primarily focused on the growth opportunity in the protected PCI area, a procedure that is applicable for patients with coronary artery disease.
In March 2017, Abiomed (ABMD) submitted premarket approval (or PMA) to the FDA for its Impella RP device far ahead of schedule.
PTEN's management believes that its merger with Seventy Seven Energy has consolidated PTEN’s position in drilling and pressure pumping activity.
In 2016, United Therapeutics (UTHR) reported ~$1.6 billion in revenues, reflecting ~9.0% YoY growth. In 1Q17, UTHR generated ~$370.0 million in revenues—an ~9.0% quarter-over-quarter decline.
NorthCoast's top holdings concentrated in U.S. and European equities continued to gain ground in Q2.
Align Technology (ALGN) is a medical device provider focused on malocclusion or teeth misalignment condition.